Related Experiment Videos
DNA methylation during chronic administration of 1,2-dimethylhydrazine in a carcinogenic regimen
Abstract:
The formation and persistence of O6-methylguanine and 7-methylguanine in colon, kidney, and liver DNA were measured over a period of 25 weeks during 1,2-dimethylhydrazine (SDMH) carcinogenesis. Rats were given 14 weekly s.c. injections of 21 mg SDMH/kg body wt., and methylated guanines in DNA were determined quantitatively one week after each injection to measure the long-term accumulation of these aberrant bases. No accumulation of either base was seen in colon DNA, and no O6-methylguanine was seen to accumulate in liver DNA. The concentrations of O6-methylguanine and 7-methylguanine in kidney DNA did increase with reported administration of the carcinogen, but these bases were removed within six weeks after the last (14th) injection of SDMH. Large amounts of 7-methylguanine accumulated in liver DNA over the 14-week treatment period. The concentration of 7-methylguanine in liver and kidney DNA increased at rates greater than could be accounted for by using kinetic relationships determined in single-exposure studies. The concentration of O6-methylguanine in kidney DNA also increase at a rate greater than would be expected from calculations based on the rate of removal following a single administration of SDMH.
Insights
This study monitored DNA damage in rats exposed to 1,2-dimethylhydrazine (SDMH). Kidney DNA showed accumulating O6-methylguanine and 7-methylguanine, while liver DNA accumulated 7-methylguanine, with rapid removal after exposure ceased.
Area of Science:
- Toxicology
- Molecular Biology
- Carcinogenesis Research
Background:
- DNA adducts like O6-methylguanine and 7-methylguanine are biomarkers of chemical carcinogen exposure.
- Understanding the kinetics of DNA adduct formation and removal is crucial for assessing cancer risk.
Purpose of the Study:
- To quantify the formation and persistence of O6-methylguanine and 7-methylguanine in rat colon, kidney, and liver DNA during chronic 1,2-dimethylhydrazine (SDMH) exposure.
- To investigate the long-term accumulation and removal kinetics of these DNA adducts.
Main Methods:
- Rats received 14 weekly subcutaneous injections of 1,2-dimethylhydrazine (SDMH).
- DNA was isolated from colon, kidney, and liver tissues at various time points.
- Quantitative analysis determined the levels of O6-methylguanine and 7-methylguanine in DNA.
Main Results:
- No accumulation of O6-methylguanine or 7-methylguanine was observed in colon DNA.
- Kidney DNA showed increased levels of both O6-methylguanine and 7-methylguanine during SDMH administration, which were cleared within six weeks post-exposure.
- Significant accumulation of 7-methylguanine occurred in liver DNA over the treatment period.
- The rates of 7-methylguanine increase in liver and kidney DNA, and O6-methylguanine in kidney DNA, exceeded predictions based on single-exposure kinetics.
Conclusions:
- Chronic SDMH exposure leads to differential accumulation of DNA adducts in various organs.
- Kidney DNA adducts are transient, while liver DNA shows persistent 7-methylguanine accumulation.
- The accelerated formation rates suggest complex metabolic or repair dynamics during chronic carcinogen exposure.